Condensed Consolidated Statements of Income (Loss) (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended	9 Months Ended
Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Net sales	$ 3,773	$ 3,226	$ 11,226	$ 9,270
Cost of sales	2,640	1,905	7,292	5,571
Gross margin	1,133	1,321	3,934	3,699
Selling, general and administrative expenses	947	680	2,975	1,982
Research and development expenses	152	129	450	396
Goodwill impairments	2,785	0	2,785	0
Other operating expense (income), net	48	(1)	20	(6)
Operating income (loss)	(2,799)	513	(2,296)	1,327
Interest expense, net	104	50	278	118
Other (income) expense, net	63	12	3	15
Income (loss) before income taxes	(2,966)	451	(2,577)	1,194
Income tax expense (benefit)	(32)	(1)	29	141
Net income (loss)	(2,934)	452	(2,606)	1,053
Net income attributable to noncontrolling interests	3	2	8	7
Net income (loss) attributable to Baxter stockholders	$ (2,937)	$ 450	$ (2,614)	$ 1,046
Earnings (loss) per share
Basic (in dollars per share)	$ (5.83)	$ 0.90	$ (5.20)	$ 2.08
Diluted (in dollars per share)	$ (5.83)	$ 0.89	$ (5.20)	$ 2.06
Weighted-average number of shares outstanding
Basic (in shares)	504	500	503	503
Diluted (in shares)	504	506	503	509

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227